IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management III, LLC

Q3 2021 Holdings

Filed 2021-11-12 | 6 holdings | $35.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics, Inc.(ACRS)COM00461U105$35.2M1,954,90499.9%
Acceleron Pharma Inc.(XLRN)COM00434H108$18.7K108,6300.1%
Verona Pharma Plc.(VRNA)SPONSORED ADS925050106$6.1K1,111,1120.0%
Cymabay Therapeutics, Inc.(CBAYUSD)COM23257D103$6.0K1,641,8040.0%
Epizyme, Inc.(EPZMEUR)COM29428V104$5.1K998,2780.0%
Novavax, Inc.(NVAX)COM670002401$1.0K5,0000.0%